The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Does The Forecasted Market Size Of The Sustained Release Excipients Market Compare Between 2026 And 2030?
The sustained release excipients market has demonstrated strong expansion over recent years. It is projected to increase from $1.51 billion in 2025 to $1.63 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.2%. This historical growth can be ascribed to several contributing factors, including the rising prevalence of chronic diseases, the greater utilization of modified release tablets, advancements in polymer chemistry, the expansion of generic drug manufacturing, and the regulatory acceptance of sustained release formulations.
The sustained release excipients market size is anticipated to experience substantial growth over the next few years. Its valuation is projected to reach $2.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. This expansion during the forecast period is primarily driven by an increasing demand for long-acting injectables, the rise of biologics and specialty drugs, greater investment in drug delivery research and development, the need for patient-centric formulations, and the expansion of pharmaceutical manufacturing operations in developing markets. Significant trends expected in the forecast period involve a growing preference for controlled drug delivery systems, the increased utilization of polymers in sustained release formulations, wider adoption of oral sustained release dosage forms, the advancement of microencapsulation and coacervation technologies, and a focus on enhancing patient compliance through reduced dosing frequency.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10822&type=smp
What Important Drivers Are Powering The Sustained Release Excipients Market Growth?
The sustained-release excipients market is projected to grow as the demand for personalized medicine continues to rise. Personalized medicine, also termed personalized care, involves medical professionals examining patients’ unique genes, proteins, and other biological components to deliver and organize tailored care using precision medicine. Sustained-release excipients are crucial in personalized medicine because they enable the development of drug formulations customized to meet individual patient needs. For instance, in February 2024, the Personalised Medicine Coalition, a US-based hospital and health care organization, reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, which is an increase from 6 in 2022. Thus, the escalating demand for personalized medicine is propelling the expansion of the sustained-release excipients market.
Which Segment Divisions Form The Structure Of The Sustained Release Excipients Market?
The sustained release excipients market covered in this report is segmented –
1) By Product: Gelatin, Polymers, Minerals, Chitosan
2) By Route of Administration: Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Other Routes of Administration
3) By Technology: Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation
Subsegments:
1) By Gelatin: Type A Gelatin, Type B Gelatin
2) By Polymers: Natural Polymers, Synthetic Polymers
3) By Minerals: Calcium Compounds, Magnesium Compounds, Other Mineral Excipients
4) By Chitosan: Low Molecular Weight Chitosan, High Molecular Weight Chitosan
What Trends Are Shaping The Sustained Release Excipients Market Structure?
Leading companies within the sustained release excipients market are prioritizing the development of advanced solutions, such as multifunctional polymer platforms, to enhance drug formulation efficiency, decrease delivery duration, and support controlled-release profiles. Multifunctional polymer platforms denote excipients capable of enabling immediate, delayed, and sustained drug release, while remaining compatible with formulation technologies like hot melt extrusion and solubility-enhancing spray drying. For example, in September 2024, Evonik, a company based in Germany, began operating a new spray drying facility at its Darmstadt location specifically for EUDRAGIT polymers. This facility boosts production capacity, shortens delivery times, and integrates completely with existing production networks. It employs green electricity and steam derived from local waste incineration to cut CO2 emissions by over 1,000 tons each year. Adhering to IPEC-GMP pharmaceutical guidelines and being directly connected to the production of aqueous dispersions, the facility reduces transportation and streamlines the supply chain. The polymers manufactured there support immediate, delayed, and sustained release formulations, thereby solidifying Evonik’s global hub for oral drug delivery solutions and strengthening its capability to efficiently support innovative pharmaceutical development.
Which Firms Are Competing In The Sustained Release Excipients Market?
Major companies operating in the sustained release excipients market are BASF SE, Ashland Global Holdings Inc, Colorcon Inc, Evonik Industries AG, Lubrizol Corporation, Merck KGaA, Roquette Freres, Shin Etsu Chemical Co Ltd, JRS Pharma GmbH Co KG, SPI Pharma Inc, Croda International Plc, Lonza Group AG, Chemische Fabrik Budenheim KG, Asahi Kasei Corporation, DuPont de Nemours Inc, Dow Chemical Company, Eastman Chemical Company, Gattefosse SAS, Balchem Corporation, Associated British Foods plc, Ransom Naturals Ltd, Cellulose Solutions Private Limited
Access The Complete Sustained Release Excipients Market Report:
https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report
Which Region Is The Primary Market For The Sustained Release Excipients Market?
North America was the largest region in the global sustained release excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sustained release excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Sustained Release Excipients Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=10822&type=smp
Browse Through More Reports Similar to the Global Sustained Release Excipients Market 2026, By The Business Research Company
Sustained Release Excipients Market Report 2026
https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report
Pharmaceutical Excipient Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Controlled Release Drug Delivery Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model